Gene advisory group wrestles with its mission.
作者信息
Jenks S
出版信息
J Natl Cancer Inst. 1995 Jul 5;87(13):959-60. doi: 10.1093/jnci/87.13.959.
PMID:7629882
Abstract
摘要
相似文献
1
Gene advisory group wrestles with its mission.基因咨询小组努力明确其使命。
J Natl Cancer Inst. 1995 Jul 5;87(13):959-60. doi: 10.1093/jnci/87.13.959.
2
Department of Health and Human Services. National Institutes of Health. Recombinant DNA Advisory Committee. Minutes of meeting. March 6-7, 1997.卫生与公众服务部。国立卫生研究院。重组DNA咨询委员会。会议记录。1997年3月6日至7日。
Hum Gene Ther. 1997 Nov 1;8(16):1955-2004. doi: 10.1089/hum.1997.8.16-1955.
3
Gene therapy review finds few complications.基因治疗综述发现并发症很少。
J Natl Cancer Inst. 1993 Aug 4;85(15):1188-90. doi: 10.1093/jnci/85.15.1188.
4
Department of Health and Human Services National Institutes of Health Recombinant DNA Advisory Committee. Minutes of meeting March 8-10, 2000.卫生与公众服务部国立卫生研究院重组DNA咨询委员会。2000年3月8日至10日会议记录。
Hum Gene Ther. 2000 Oct 10;11(15):2159-92. doi: 10.1089/104303400750001453.
5
What ever happened to ...?: A 10-year retrospective.
J Natl Cancer Inst. 1999 Jan 20;91(2):114-7. doi: 10.1093/jnci/91.2.114.
6
Assessment of adenoviral vector safety and toxicity: report of the National Institutes of Health Recombinant DNA Advisory Committee.腺病毒载体安全性和毒性评估：美国国立卫生研究院重组DNA咨询委员会报告
Hum Gene Ther. 2002 Jan 1;13(1):3-13. doi: 10.1089/10430340152712629.
7
Gene therapy on the RAC.
Mol Ther. 2000 Jan;1(1):1-2. doi: 10.1006/mthe.1999.0022.
8
U.S. Department of Health and Human Services, National Institutes of Health. Recombinant DNA Advisory Committee: minutes of meeting, December 13 & 15, 2000.美国卫生与公众服务部，国立卫生研究院。重组DNA咨询委员会：2000年12月13日及15日会议记录
Hum Gene Ther. 2001 Aug 10;12(12):1559-84. doi: 10.1089/10430340152480285.
9
NIH Recombinant DNA Advisory Committee data management report. June 18-19, 1998.
Hum Gene Ther. 1998 Sep 20;9(14):2143-61. doi: 10.1089/hum.1998.9.14-2143.
10
Public oversight is necessary if human gene therapy is to progress.如果人类基因治疗要取得进展，公众监督是必要的。
Hum Gene Ther. 1996 May 1;7(7):795-7. doi: 10.1089/hum.1996.7.7-795.
Zotero 插件